Home » Topics » Immuno-oncology, BioWorld Science

Immuno-oncology, BioWorld Science
RSS

Preclinical results for DC101 presented at AACR

April 26, 1996

GVAX cleared to enter phase III testing

April 26, 1996

Mitsubishi in-licenses anti-HER2, will begin clinical evaluation soon

April 26, 1996

Alnorin reported in phase I

April 19, 1996

BR96 produced successfully in milk from transgenic goats

April 12, 1996

Virulizin clinical trials resume in pancreatic cancer

April 12, 1996

Virulizin clinical trials reinitiated for KS

April 12, 1996

MAbs for treatment of melanoma

April 5, 1996

IDEC-C2B8 development update

March 15, 1996

Virogenetics cancer vaccine in phase I/II trials

March 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for April 23, 2025.
Biopharma restructurings reflect strategy of short-term pain for long-term gains
BioWorld
Ongoing restructurings in the biopharma sector show common themes of cost-cutting, clinical failures and shifting strategic priorities. Companies are increasingly...
Field Medical harvests $40M for PFA system
BioWorld MedTech
Field Medical Inc. reaped $40 million in its series A fundraising via $20 million in new capital and conversion of $20 million in seed-round debt to support...
Roche follows other pharmas, committing $50B in US investment
BioWorld
Roche AG has become the latest pharmaceutical company to respond to the Trump administration’s threat to impose tariffs, saying it will invest $50 billion in drug...